Our History

After many years of cherishing aspirations to reach out, by 2023 Ypharco has affirmed a solid position in the Vietnamese traditional medicine industry.

Ypharco has fully converged strengths: modern production technology, superior drug production formula, products are widely distributed across the country.

In March 2017, Yen Bai Pharmaceutical Joint Stock Company (Ypharco) became a subsidiary of Bepharco, which Bepharco owns with the rate of 51.84%.
Ininaugurating new drugs factory and with a total floor area of 2,800m2, and become the only enterprise in the 14 northern mountainous provinces to have a drug factory that meets GMP-WHO certificate
In 2010, Yen Bai Pharmaceutical was awarded the certificate of top 100 leading Vietnamese brands by the Vietnam Union of Science and Technology Associations.
Starting to upgrade and expand the drug factory with a total floor area of 2,800m2, and become the only enterprise in the 14 northern mountainous provinces to have a drug factory that meets the following standards: "Practice practice Good Drug Manufacturing” (GMP-WHO)
From December 2002, the Company went into equitization with the name Yen Bai Pharmaceutical Joint Stock Company (Ypharco).
In 1996, Yen Bai Pharmaceutical Company was established on the basis of merging two companies and Yen Bai Pharmaceutical Factory.